000299494 001__ 299494
000299494 005__ 20250901115823.0
000299494 0247_ $$2doi$$a10.1186/s13053-024-00303-6
000299494 0247_ $$2pmid$$apmid:40016794
000299494 0247_ $$2ISSN$$a1731-2302
000299494 0247_ $$2ISSN$$a1897-4287
000299494 037__ $$aDKFZ-2025-00453
000299494 041__ $$aEnglish
000299494 082__ $$a610
000299494 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$udkfz
000299494 245__ $$aHigh familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers.
000299494 260__ $$aHeidelberg$$bSpringer$$c2025
000299494 3367_ $$2DRIVER$$aarticle
000299494 3367_ $$2DataCite$$aOutput Types/Journal article
000299494 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756720669_32342$$xReview Article
000299494 3367_ $$2BibTeX$$aARTICLE
000299494 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000299494 3367_ $$00$$2EndNote$$aJournal Article
000299494 500__ $$a#EA:Z999#LA:B062#
000299494 520__ $$aGermline genetic susceptibilities of rare cancers of the esophagus, stomach, small intestine, testis, (nonmedullary) thyroid gland and bone with high familial risks are not well known. Here, we use familial risk data from the Swedish Family-Cancer Database which contains records of cancers in Swedish families obtained over a century. We compare familial risks for offspring diagnosed with any of these cancers when their parent had or had not that cancer. We review the global literature of the reported constitutional variants that may explain part of the familial risk.Familial risks for esophageal and stomach cancers are about 2.0 and apart from early-onset stomach cancer few high-risk variants are known. Genetic studies may be hampered by dominant environmental risk factors for these cancers. Small intestinal carcinoids have a very high familial risk (28 between siblings) but no high-risk genes have been identified to explain this. Low-risk polygenic variants have been identified. Small intestinal adenocarcinoma is a manifestation in Lynch syndrome. Testicular and thyroid cancers are characterized by high familial risk (about 5) which may be explained largely by a polygenic background, although thyroid cancer is a component in a number of rare cancer syndromes. Several predisposing genes have been identified for bone cancer (familial risk 7).The discussed cancers are rare and they present with a relatively high familial risk, in spite of lacking identified high-penetrant constitutional variants. It is possible that the polygenic component, already recognized for testis cancer, is stronger than previously expected. Thus polygenic models with rare high/moderate- and low-risk variants could fit the familial risk and shape the germline genetic landscape of these cancers. Polygenic background may have clinical implications.
000299494 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000299494 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000299494 650_7 $$2Other$$aConstitutional variants
000299494 650_7 $$2Other$$aFamilial risk
000299494 650_7 $$2Other$$aGermline genetics
000299494 650_7 $$2Other$$aHeredity
000299494 7001_ $$aHemminki, Otto$$b1
000299494 7001_ $$aKoskinen, Anni$$b2
000299494 7001_ $$aHemminki, Akseli$$b3
000299494 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b4$$eLast author$$udkfz
000299494 773__ $$0PERI:(DE-600)2233352-6$$a10.1186/s13053-024-00303-6$$gVol. 23, no. 1, p. 9$$n1$$p9$$tHereditary cancer in clinical practice$$v23$$x1731-2302$$y2025
000299494 909CO $$ooai:inrepo02.dkfz.de:299494$$pVDB
000299494 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000299494 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000299494 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000299494 9141_ $$y2025
000299494 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:39:48Z
000299494 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:39:48Z
000299494 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-04-10T15:39:48Z
000299494 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHERED CANCER CLIN PR : 2022$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-16
000299494 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-16
000299494 9202_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000299494 9201_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x0
000299494 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000299494 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000299494 9200_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x0
000299494 980__ $$ajournal
000299494 980__ $$aVDB
000299494 980__ $$aI:(DE-He78)Z999-20160331
000299494 980__ $$aI:(DE-He78)B062-20160331
000299494 980__ $$aI:(DE-He78)HD01-20160331
000299494 980__ $$aUNRESTRICTED